Michael May, MD
Family Medicine · Hattiesburg, MSNPI 1356345979
Payments from drug & device makers
Across 431 payments — averaging $13.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$995
- AstraZeneca$849
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$613
- Amgen$580
- Novo Nordisk$561
- Boehringer Ingelheim$235
- plus $2K from 26 others
What the payments were for
- Food & beverage$5,875100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 109 | $995 |
| AstraZeneca | 43 | $849 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 41 | $613 |
| Amgen | 47 | $580 |
| Novo Nordisk | 37 | $561 |
| Boehringer Ingelheim | 18 | $235 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $231 |
| Johnson & Johnson | 15 | $193 |
| Astellas Pharma US Inc | 11 | $163 |
| Merck | 11 | $154 |
| Pfizer | 10 | $145 |
| Biohaven Pharmaceuticals, Inc. | 9 | $130 |
| GSK | 9 | $129 |
| Teva Pharmaceuticals USA, Inc. | 8 | $128 |
| Genentech USA, Inc. | 9 | $124 |
| Smith+Nephew | 7 | $113 |
| E.r. Squibb & Sons, L.L.C. | 5 | $72 |
| Eisai Inc. | 4 | $60 |
| Novartis | 3 | $57 |
| Shire North American Group Inc | 4 | $55 |
| Lilly USA, LLC | 4 | $55 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $44 |
| Sunovion Pharmaceuticals Inc. | 2 | $40 |
| Amarin Pharma, Inc. | 2 | $31 |
| Nestle Healthcare Nutrition Inc. | 2 | $29 |
| Medtronic | 1 | $19 |
| Boston Scientific | 1 | $15 |
| Ironshore Pharmaceuticals Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Seqirus USA Inc | 1 | $13 |
| Melinta Therapeutics, LLC | 1 | $11 |
| Avanir Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYMBICORT$235
- FARXIGA$235
- BREZTRI AEROSPHERE$132
How this compares
$5,881 in reported general payments places this provider in the 85th percentile of 971 family medicine providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Hattiesburg
- Rambod RouhbakhshHattiesburg$6M
- Omolara OtaigbeHattiesburg$17K
- Deborah CopelandHattiesburg$13K
- J DumasHattiesburg$12K
- Anny EvansHattiesburg$10K
- Paul MatherneGulfport$14.4M
- Timothy QuinnRidgeland$8M
- Sean KerbyGulfport$6.6M
- Randall HulingOlive Branch$4.6M
- Demetri MarshallPort Gibson$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.